RB1 and neoplasm: With similar intent, SCNA profiling via low-pass whole genome sequencing (WGS) has been utilized to investigate RB1 loss on chromosome 13, along with additional RB-SCNA signatures (i.e., chr6p gains), in both AH and tumor samples.